Delivery Order SPE2DB20D3101-SPE2DB25FRSJ7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,688.89 to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price delivery order, issued without set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is a rescue medication indicated for acute repetitive seizure episodes in patients with epilepsy, representing a critical specialty...
- The Defense Logistics Agency awarded a delivery order valued at $3,364.29 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays on August 14, 2025, with completion scheduled for August 15, 2025. This competitively awarded, firm fixed-price contract was issued with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Valtoco is a rescue medication used in emergency seizure management, reflecting the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at $4,226.52 to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays, with performance in Conshohocken, Pennsylvania and an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was awarded competitively with no set-aside designation on July 18, 2025. Valtoco is a seizure rescue medication used for acute repetitive seizure clusters, representing a specialized pharmaceutical product critical to military...
- The Defense Logistics Agency awarded a delivery order valued at $4,504.40 to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a rescue medication indicated for acute repetitive seizures, representing specialized...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Valtoco is a seizure rescue medication used for acute repetitive seizure clusters, representing a specialized...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,128.54 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, with performance in Conshohocken, Pennsylvania and completion by July 23, 2025. This contract was competitively awarded with no set-aside designation and utilizes firm fixed-price pricing typical of DLA pharmaceutical procurement. Valtoco is a rescue medication indicated for acute repetitive seizure episodes, reflecting the broad therapeutic scope of...
- The Defense Logistics Agency awarded a delivery order valued at $1,141.96 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal spray on July 29, 2025, with a completion date of July 30, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a nasal spray formulation used for acute seizure management, reflecting the breadth of...
- The Defense Logistics Agency awarded a delivery order valued at $2,301.07 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, effective July 24, 2025, with completion targeted for July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is a rescue medication indicated for acute seizure management, reflecting the pharmaceutical supply needs of...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 12, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded on August 11, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a rescue medication used for acute repetitive seizure clusters in epilepsy...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Valtoco 10 mg nasal sprays, with a contract ceiling value of $2,259.24 and an ultimate completion date of July 21, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Valtoco is a...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRSJ7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, valued at $13,527.84 on August 12, 2025, with completion expected by August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is a rescue medication used for acute seizure management, reflecting the Defense Logistics Agency's medical supply procurement needs for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated significant capability in fulfilling federal medical procurement requirements through multiple competitively awarded delivery orders with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.5k | 8/12/25 |